Literature DB >> 11564425

Differential expression of AMPA receptor subunits in dopamine neurons of the rat brain: a double immunocytochemical study.

L W Chen1, L C Wei, B Lang, G Ju, Y S Chan.   

Abstract

We have examined the distribution of dopamine neurons expressing alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA) receptor subunits (glutamate receptors 1, 2/3 and 4) in the A8-A15 regions of the rat brain using double immunofluorescence. The distribution of glutamate receptor 1- or 2/3-like immunoreactive neurons completely overlapped that of tyrosine hydroxylase-like immunoreactive neurons in dopamine cell groups in the retrorubral field (A8), the substantia nigra (A9), the ventral tegmental area and the nucleus raphe linealis (A10), and the rostral hypothalamic periventricular nucleus (A14, A15). In the caudal hypothalamic periventricular nucleus (A11), arcuate nucleus (A12) and zona incerta (A13), the distribution was partially overlapping. Neurons double-labeled for tyrosine hydroxylase and glutamate receptor 1 or 2/3 immunoreactivities were, however, exclusively found in certain dopamine cell regions: in areas A14-A15, 85-88% of tyrosine hydroxylase-containing neurons expressed glutamate receptor 1 and 22-25% expressed glutamate receptor 2/3, while in areas A8-A10, 20-43% expressed glutamate receptor 1 and 63-84% expressed glutamate receptor 2/3. In contrast, the double-labeled neurons were hardly detected in the A11-A13 regions. No tyrosine hydroxylase-positive neurons displayed glutamate receptor 4 immunoreactivity, though a partially overlapping distribution of tyrosine hydroxylase- and glutamate receptor 4-immunopositive neurons was also seen in regions A8-10, A11 and A13. The present study has demonstrated the morphological evidence for direct modulation of dopamine neurons via AMPA receptors in rat mesencephalon and hypothalamus. This distribution may provide the basis for a selective dopamine neuron loss in neurodegenerative disorders, such as Parkinson's disease.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11564425     DOI: 10.1016/s0306-4522(01)00255-x

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  8 in total

1.  Alterations in ionotropic glutamate receptor subunits during binge cocaine self-administration and withdrawal in rats.

Authors:  Wenxue Tang; Michael Wesley; Willard M Freeman; Bill Liang; Scott E Hemby
Journal:  J Neurochem       Date:  2004-05       Impact factor: 5.372

2.  BDNF mediates the neuroprotective effects of positive AMPA receptor modulators against MPP+-induced toxicity in cultured hippocampal and mesencephalic slices.

Authors:  H Jourdi; L Hamo; T Oka; A Seegan; M Baudry
Journal:  Neuropharmacology       Date:  2009-01-21       Impact factor: 5.250

3.  Decreased sensitivity of NMDA receptors on dopaminergic neurons from the posterior ventral tegmental area following chronic nondependent alcohol consumption.

Authors:  Griffin J Fitzgerald; Hai Liu; Sandra L Morzorati
Journal:  Alcohol Clin Exp Res       Date:  2012-03-20       Impact factor: 3.455

Review 4.  N-Methyl-D-aspartate receptors as a target for improved antipsychotic agents: novel insights and clinical perspectives.

Authors:  Mark J Millan
Journal:  Psychopharmacology (Berl)       Date:  2005-03-10       Impact factor: 4.530

5.  Upregulation of ionotropic glutamate receptor subunits within specific mesocorticolimbic regions during chronic nicotine self-administration.

Authors:  Fan Wang; Hao Chen; Jeffery D Steketee; Burt M Sharp
Journal:  Neuropsychopharmacology       Date:  2006-02-01       Impact factor: 7.853

6.  Electrical synapses between dopaminergic neurons of the substantia nigra pars compacta.

Authors:  Marie Vandecasteele; Jacques Glowinski; Laurent Venance
Journal:  J Neurosci       Date:  2005-01-12       Impact factor: 6.167

7.  Involvement of AMPA receptor GluR2 subunits in stimulus-reward learning: evidence from glutamate receptor gria2 knock-out mice.

Authors:  Andy N Mead; David N Stephens
Journal:  J Neurosci       Date:  2003-10-22       Impact factor: 6.167

8.  Ketamine enhances structural plasticity in mouse mesencephalic and human iPSC-derived dopaminergic neurons via AMPAR-driven BDNF and mTOR signaling.

Authors:  L Cavalleri; E Merlo Pich; M J Millan; C Chiamulera; T Kunath; P F Spano; G Collo
Journal:  Mol Psychiatry       Date:  2017-11-21       Impact factor: 15.992

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.